Immunovant, Inc. (IMVT) has 183 open-market insider trades by 18 insiders since 2020. Over the last six months insiders net sold $13.1M. The most active filer is Peter Salzmann, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. | Dir10% Owner | — | 6 | $789.9M | 2025-12-12 |
| Peter Salzmann | CEO | — | 33 | $24.3M | 2025-04-16 |
| Andrew J. Fromkin | Dir | — | 2 | $7.5M | 2026-05-28 |
| Eva Renee Barnett | CFO | — | 24 | $5.9M | 2025-04-16 |
| Julia G. Butchko | — | — | 24 | $5.2M | 2024-08-21 |
| Mark S. Levine | CLO | — | 17 | $4.0M | 2024-11-20 |
| William L. Macias | — | — | 21 | $3.6M | 2025-02-19 |
| Jay S. Stout | CTO | — | 17 | $3.4M | 2026-07-23 |
| Melanie Gloria | COO | — | 8 | $2.0M | 2026-10-07 |
| Michael Geffner | — | — | 11 | $1.8M | 2025-10-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jay S. Stout | CTO | Sell | $122K | 2026-10-07 |
| Christopher van Tuyl | CLO | Sell | $43K | 2026-10-07 |
| Melanie Gloria | COO | Sell | $72K | 2026-10-07 |
| Eric Venker | CEO | Sell | $120K | 2026-10-02 |
| Christopher van Tuyl | CLO | Sell | $103K | 2026-09-23 |
| Atul Pande | Director | Sell | $65K | 2026-08-28 |
Companies that share insiders with IMVT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Melanie Gloria | COO | Sell | $135K | 2026-08-20 |
| Atul Pande | Director | Sell | $60K | 2026-07-24 |
| Tiago Girao | CFO | Sell | $263K | 2026-07-23 |
| Jay S. Stout | CTO | Sell | $111K | 2026-07-23 |
| Christopher van Tuyl | CLO | Sell | $48K | 2026-07-08 |
| Melanie Gloria | COO | Sell | $81K | 2026-07-08 |
| Jay S. Stout | CTO | Sell | $138K | 2026-07-08 |
| Eric Venker | CEO | Sell | $119K | 2026-07-02 |
| Jay S. Stout | CTO | Sell | $1.5M | 2026-06-26 |